PT-141 10mg
For Research Purposes Only. Not intended for human consumption.
PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide and melanocortin receptor agonist derived from the peptide Melanotan II. Unlike its predecessor, PT-141 does not activate melanocortin receptors responsible for pigmentation, making it a more selective research tool for studying central melanocortin pathways.
## Research Overview
Research into PT-141 has examined its activity at MC3R and MC4R receptors in the central nervous system. Studies have explored its role in hypothalamic signaling pathways and neuroendocrine modulation. PT-141 is among the few peptides studied specifically for centrally-mediated receptor pathway research distinct from peripheral mechanisms.
## Key Research Areas
– MC3R and MC4R receptor agonist activity in CNS models
– Hypothalamic signaling and neuroendocrine pathway research
– Melanocortin system modulation independent of pigmentation
– Central nervous system peptide receptor binding studies
– Comparative receptor selectivity vs. Melanotan II
## Product Specifications
– **Form:** Lyophilized powder
– **Purity:** ≥99% (HPLC verified)
– **Quantity:** 10mg per vial
– **Testing:** Independent third-party COA available
– **Storage:** Store at -20°C. Stable at 4°C short-term.
– **CAS Number:** 189691-06-3
*For laboratory research purposes only. Not approved for human or veterinary use.*
